Showing results (61-70 of 95) with videos related to

Sort By:
Pageof 10
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2017
T Cells Expressing Checkpoint Receptor TIGIT Are Enriched in Follicular Lymphoma Tumors and Characterized by Reversible Suppression of T-cell Receptor SignalingSarah E Josefsson, Kanutte Huse, Arne Kolstad, et al.
The Lancet. Haematology|February 4, 2018
Ibrutinib, lenalidomide, and rituximab in relapsed or refractory mantle cell lymphoma (PHILEMON): a multicentre, open-label, single-arm, phase 2 trialMats Jerkeman, Christian Winther Eskelund, Martin Hutchings, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|September 6, 2013
High-dose therapy with autologous stem cell support for lymphoma in Norway 1987-2008Knut Bjøro Smeland, Cecilie E Kiserud, Grete F Lauritzsen, et al.
Cancer Immunology Research|January 20, 2019
TIGIT and PD-1 Mark Intratumoral T Cells with Reduced Effector Function in B-cell Non-Hodgkin LymphomaSarah E Josefsson, Klaus Beiske, Yngvild N Blaker, et al.
Virchows Archiv : an International Journal of Pathology|November 5, 2021
Clinical and biological impact of SAMHD1 expression in mantle cell lymphomaMagali Merrien, Agata M Wasik, Elin Ljung, et al.
Blood|December 25, 2016
Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profilingJune H Myklebust, Joshua Brody, Holbrook E Kohrt, et al.
Genes|June 26, 2025
Exploring the Prognostic Potential of circSCORE in Patients with Relapsed/Refractory Mantle Cell LymphomaRuth Salim, Christian Winther Eskelund, Mats Jerkeman, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|September 3, 2014
[Allogeneic stem-cell transplantation in adults 1985-2012: results and development]Magnus Andreas Rognlien Husøy, Lorentz Brinch, Geir E Tjønnfjord, et al.
Pageof 10